The retrovirus Human T-lymphotropic virus type 1 (HTLV-1) preferentially infects CD4+ T-cells via cell-to-cell transmission, while cell-free infection of T-cells is inefficient. Substantial insights into the different routes of transmission have largely been obtained by imaging techniques or by flow cytometry. Recently, strategies to quantify infection events with HTLV-1 improved. In this chapter, we present two different methods to quantitate virus transmission. Both methods are based on measuring gene activity of luciferase with a cost-saving in-house luciferase assay. First, we established a reporter Jurkat T-cell line carrying a luciferase gene under the control of the HTLV-1 core promoter U3R. Upon co-culture with chronically HTLV-1-infected T-cell lines, reporter cells are infected, and upon expression of the viral transactivator Tax, the viral promoter is activated resulting in enhanced luciferase activity. However, this assay as presented here does not exclude cell fusion as the mechanism allowing intracellular Tax-dependent activation of luciferase gene expression. Therefore, we describe a second method, the single-cycle replication-dependent reporter system developed by Mazurov et al. (PLoS Pathog 6:e1000788, 2010) that allows quantitation of HTLV-1 infection in co-cultured cells. Taken together, both methods facilitate quantitation of HTLV-1 transmission and will help to unravel pathways required for cell-to-cell transmission on a quantitative basis.
This is a preview of subscription content, log in to check access.
Springer Nature is developing a new tool to find and evaluate Protocols. Learn more
This work was supported by the DFG (SFB 796, C6).
The authors are grateful to Gisela Heidecker-Fanning from the laboratory of the late David Derse (HIV Drug Resistance Program, National Cancer Institute-Frederick, Frederick, Maryland, United States of America) for providing the single-cycle replication-dependent reporter system.
The authors disclaim all liability for direct or consequential damages resulting from the use of the methods described in this chapter.
Igakura T, Stinchcombe JC, Goon PK et al (2003) Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science 299:1713–1716CrossRefPubMedGoogle Scholar
Jones KS, Petrow-Sadowski C, Huang YK et al (2008) Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells. Nat Med 14:429–436CrossRefPubMedGoogle Scholar
Pais-Correia AM, Sachse M, Guadagnini S et al (2010) Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses. Nat Med 16:83–89CrossRefPubMedGoogle Scholar
Van Prooyen N, Andresen V, Gold H et al (2010) Hijacking the T-cell communication network by the human T-cell leukemia/lymphoma virus type 1 (HTLV-1) p12 and p8 proteins. Mol Aspects Med 31:333–343CrossRefPubMedPubMedCentralGoogle Scholar
Pare ME, Gauthier S, Landry S et al (2005) A new sensitive and quantitative HTLV-I-mediated cell fusion assay in T cells. Virology 338:309–322CrossRefPubMedGoogle Scholar
Astier-Gin T, Portail JP, Lafond F et al (1995) Identification of HTLV-I- or HTLV-II-producing cells by cocultivation with BHK-21 cells stably transfected with a LTR-lacZ gene construct. J Virol Methods 51:19–29CrossRefPubMedGoogle Scholar
Cachat A, Chevalier SA, Alais S et al (2013) Alpha interferon restricts human T-lymphotropic virus type 1 and 2 de novo infection through PKR activation. J Virol 87:13386–13396CrossRefPubMedPubMedCentralGoogle Scholar
Delamarre L, Rosenberg AR, Pique C et al (1997) A novel human T-leukemia virus type 1 cell-to-cell transmission assay permits definition of SU glycoprotein amino acids important for infectivity. J Virol 71:259–266PubMedPubMedCentralGoogle Scholar
Mazurov D, Ilinskaya A, Heidecker G et al (2010) Quantitative comparison of HTLV-1 and HIV-1 cell-to-cell infection with new replication dependent vectors. PLoS Pathog 6:e1000788CrossRefPubMedPubMedCentralGoogle Scholar
Mann MC, Strobel S, Fleckenstein B et al (2014) The transcription elongation factor ELL2 is specifically upregulated in HTLV-1-infected T-cells and is dependent on the viral oncoprotein tax. Virology 464-465C:98–110CrossRefGoogle Scholar
Smith MR, Greene WC (1990) Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes. Genes Dev 4:1875–1885CrossRefPubMedGoogle Scholar
Shunaeva A, Potashnikova D, Pichugin A et al (2015) Improvement of HIV-1 and human T Cell lymphotropic virus Type 1 replication-dependent vectors via optimization of reporter gene reconstitution and modification with intronic short hairpin RNA. J Virol 89:10591–10601CrossRefPubMedPubMedCentralGoogle Scholar
Derse D, Hill SA, Lloyd PA et al (2001) Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors. J Virol 75:8461–8468CrossRefPubMedPubMedCentralGoogle Scholar
Yoshida M, Miyoshi I, Hinuma Y (1982) Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A 79:2031–2035CrossRefPubMedPubMedCentralGoogle Scholar
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254CrossRefPubMedGoogle Scholar
Rimsky L, Hauber J, Dukovich M et al (1988) Functional replacement of the HIV-1 rev protein by the HTLV-1 rex protein. Nature 335:738–740CrossRefPubMedGoogle Scholar
Mohr CF, Gross C, Bros M et al (2015) Regulation of the tumor marker Fascin by the viral oncoprotein Tax of human T-cell leukemia virus type 1 (HTLV-1) depends on promoter activation and on a promoter-independent mechanism. Virology 485:481–491CrossRefPubMedGoogle Scholar
Alais S, Mahieux R, Dutartre H (2015) Viral source-independent high susceptibility of dendritic cells to human T-cell leukemia virus Type 1 infection compared to that of T lymphocytes. J Virol 89:10580–10590CrossRefPubMedPubMedCentralGoogle Scholar
Tanaka Y, Zeng L, Shiraki H et al (1991) Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization. J Immunol 147:354–360PubMedGoogle Scholar
Saito M, Tanaka R, Fujii H et al (2014) The neutralizing function of the anti-HTLV-1 antibody is essential in preventing in vivo transmission of HTLV-1 to human T cells in NOD-SCID/gammacnull (NOG) mice. Retrovirology 11:74PubMedPubMedCentralGoogle Scholar
Jaworski E, Narayanan A, Van DR et al (2014) Human T-lymphotropic virus type 1-infected cells secrete exosomes that contain Tax protein. J Biol Chem 289:22284–22305CrossRefPubMedPubMedCentralGoogle Scholar